Page last updated: 2024-09-03

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and d 609

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with d 609 in 1 studies

Compound Research Comparison

Studies
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)
Trials
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)
Recent Studies (post-2010)
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)
Studies
(d 609)
Trials
(d 609)
Recent Studies (post-2010) (d 609)
2102270048

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shigeta, S1

Reviews

1 review(s) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and d 609

ArticleYear
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.
    Expert opinion on investigational drugs, 2000, Volume: 9, Issue:2

    Topics: Amides; Animals; Antibodies, Monoclonal; Antiviral Agents; Biopolymers; Bridged-Ring Compounds; Catechin; Drugs, Investigational; Heterocyclic Compounds; Humans; Immunoglobulins, Intravenous; Lipids; N-Acetylneuraminic Acid; Norbornanes; Oligodeoxyribonucleotides, Antisense; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Ribonucleosides; Ribose; Risk Factors; Thiocarbamates; Thiones

2000